NCT01047241View on ClinicalTrials.gov

Nasal Administration of Sufentanil+Ketamine for Procedure-related Pain in Children

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Pain
Interventions
DRUG

Intranasal sufentanil/ketamine

Nasal spray sufentanil+ketamine, 0,5 microg/kg sufentanil+0,5 mg/kg ketamine, single dose

Trial Locations (1)

2100

Copenhagen University Hospital Rigshospitalet, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Danish University of Pharmaceutical Sciences

OTHER